Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | CA2 | P00918 | 8/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 4/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27907659 | 0.98 | FDPS (0.42) | FDPSALDH1A1CA2MAPK1CA1 | |
| Hydrochloric Acid SCHEMBL29015267 | 0.98 | FDPS (0.42) | FDPSALDH1A1CA2MAPK1CA1 | |
| SCHEMBL29282631 | 0.91 | FDPS (0.50) | FDPSDNM1CYP3A4 | |
| SCHEMBL4891440 | 0.86 | FDPS (0.38) | FDPSALDH1A1CA2MAPK1CA1 | |
| SCHEMBL8565944 | 0.85 | LMNA (0.41) | FDPSALDH1A1CA2CA1 | |
| SCHEMBL1289368 | 0.84 | ALDH1A1 (0.43) | FDPSALDH1A1CA2MAPK1CA1 | |
| SCHEMBL27878198 | 0.84 | ALDH1A1 (0.32) | FDPSALDH1A1SMN1; SMN2 | |
| SCHEMBL4887829 | 0.83 | FDPS (0.43) | FDPSALDH1A1CA1SMN1; SMN2CYP3A4 | |
| SCHEMBL4883951 | 0.82 | SMN1; SMN2 (0.35) | FDPSALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL17559999 | 0.81 | FDPS (0.44) | FDPSALDH1A1CA2MAPK1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3771462-B1 | COSMETIC COMPOSITIONS TO PREVENT AND/OR AMELIORATE SKIN AGING AND METHODS OF APPLICATIONS | ORIENT EUROPHARMA CO LTD (TW) | 2025-12-03 | — | — | EP | disclosed |
| US-20250230374-A1 | DUAL-USE COOLANT AND LUBRICANT | CUMMINS INC. (US) | 2025-07-17 | — | — | US | disclosed |
| EP-4422902-A1 | DUAL-USE COOLANT AND LUBRICANT | Cummins, Inc. (US) | 2024-09-04 | — | — | EP | disclosed |
| CN-118139756-A | Dual-purpose coolant and lubricant | 康明斯公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-112294686-B | Cosmetic composition for preventing and/or improving skin aging and application thereof | 友华生技医药股份有限公司 | 2024-01-16 | — | — | CN | disclosed |
| WO-2023076170-A1 | DUAL-USE COOLANT AND LUBRICANT | CUMMINS INC. (US) | 2023-05-04 | — | — | WO | disclosed |
| US-11452681-B2 | Cosmetic compositions to prevent and/or ameliorate skin aging and methods of applications | ORIENT EUROPHARMA CO., LTD. (TW) | 2022-09-27 | — | — | US | disclosed |
| CN-110302087-B | Repairing composition, application and skin care composition containing repairing composition | 广州立白企业集团有限公司 | 2022-07-19 | — | — | CN | disclosed |
| US-20210030655-A1 | COSMETIC COMPOSITIONS TO PREVENT AND/OR AMELIORATE SKIN AGING AND METHODS OF APPLICATIONS | ORIENT EUROPHARMA CO., LTD. (TW) | 2021-02-04 | — | — | US | disclosed |
| EP-3771462-A1 | COSMETIC COMPOSITIONS TO PREVENT AND/OR AMELIORATE SKIN AGING AND METHODS OF APPLICATIONS | Orient Europharma Co Ltd (TW) | 2021-02-03 | — | — | EP | disclosed |
| US-4767568-A | Foam inhibitors for aqueous systems and use thereof | CIBA-GEIGY CORPORATION (US) | 1988-08-30 | — | — | US | disclosed |
| EP-0263069-A2 | Anti-foam agent for aqueous systems and its use | CIBA-GEIGY AG (CH) | 1988-04-06 | — | — | EP | disclosed |
| EP-0207002-A2 | Defoaming products for acquous systems, and their use | CIBA-GEIGY AG (CH) | 1986-12-30 | — | — | EP | disclosed |
| US-4405329-A | WATER OR SOLVENT SOLUTIONS OF MONO-OR POLYAZO OR ANTRAQUINONE DYES AND NONIONIC SURFACTANT; LEATHER; PAPER; TEXTILES | CIBA-GEIGY CORPORATION (US) | 1983-09-20 | — | — | US | disclosed |
| US-4341656-A | ACID SALT, SURFACTANT, ALCOHOL, SOLVENT | CIBA-GEIGY CORPORATION (US) | 1982-07-27 | — | — | US | disclosed |
| US-4328220-A | Non-dusty pulverulent and granulated organic dye preparations | CIBA-GEIGY CORPORATION (US) | 1982-05-04 | — | — | US | disclosed |
| US-4322415-A | Stable concentrated liquid preparations of metal complex dyes | CIBA-GEIGY CORPORATION (US) | 1982-03-30 | — | — | US | disclosed |
| US-4161575-A | TRIETHYLENEDIAMINE SALT OF THIOCYANIC ACID | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1979-07-17 | — | — | US | disclosed |
| US-4092266-A | ANIONIC SURFACTANT, SILICONE OIL, ALCOHOL OR ETHERIFIED AND/OR ESTERIFIED POLYOXYALKYLENE GLYCOL | CIBA-GEIGY CORPORATION (US) | 1978-05-30 | — | — | US | disclosed |
| US-4071468-A | ANIONIC SURFACTANTS | CIBA-GEIGY CORPORATION (US) | 1978-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11452681-B2 | Cosmetic compositions to prevent and/or ameliorate skin aging and methods of applications | PHOSPHO1, CUTA, PTEN | FDPS 1240/4885ALDH1A1 3264/4885CA2 3936/4885 |
| US-20210030655-A1 | COSMETIC COMPOSITIONS TO PREVENT AND/OR AMELIORATE SKIN AGING AND METHODS OF APPLICATIONS | PHOSPHO1, CUTA, PTEN | FDPS 1240/4885ALDH1A1 3264/4885CA2 3936/4885 |
| US-20250230374-A1 | DUAL-USE COOLANT AND LUBRICANT | ADH1A, ADH1C, MUC1 | FDPS 4853/4885ALDH1A1 28/4885CA2 1870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.